#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypochromic anaemia Subdural haematoma Pancreatic neuroendocrine tumour Hepatitis D Ataxia telangiectasia Anti-glomerular basement membrane disease Gastroenteropancreatic neuroendocrine tumour disease Cystic fibrosis lung Penile squamous cell carcinoma Acquired haemophilia Neuroblastoma recurrent Neuromyelitis optica spectrum disorder Krabbe's disease Ocular lymphoma VEXAS syndrome More trials…

    Learn about Rare Diseases

    Mastocytosis Small intestine leiomyosarcoma – Treatment Skin angiosarcoma – Treatment Hereditary motor and sensory neuropathy Crigler-Najjar syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Angiosarcoma non-metastatic – Diagnostics Encephalitis autoimmune – Trials in Disease Ehlers-Danlos syndrome Pituitary-dependent Cushing’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcifediol Iclepertin Tofacitinib Chlorpromazine Pariglasgene Brecaparvovec Islatravir Zoledronic Acid Nvl-655 Eik1003 Tumor Necrosis Factor-Alpha Timbetasin Acetate Phenprocoumon Piritramide Rucaparib Mk-1942 Blinatumomab Amivantamab Calcium Folinate Pentahydrate Gt005 Lifileucel More therapies…

    Learn about Your Condition

    Oesophageal food impaction Septic shock Turner's syndrome Rectal cancer stage II Cutaneous calcification Eosinophilic gastritis Pseudomonas infection Urethral valves Hypoaesthesia Pancreaticoduodenectomy Patent ductus arteriosus Arrhythmia supraventricular Renal cancer Pulmonary venous thrombosis Squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Alergo-Med Specjalistyczna Przychodnia Lekarska Sp….

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z o.o.

Pck 26 Street, Tarnow, 33-100, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of OM-85 for Children Aged 6 Months to 5 Years with Recurrent Wheezing

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Wheezing
    Hungary Poland

  • Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Bulgaria Czechia Germany Greece Hungary Italy +5

  • Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    • Wheezing
    Investigated Drugs:
    • Budesonide
    • Dupilumab
    • Fluticasone
    Czechia France Germany Greece Hungary Italy +3

  • Study on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Czechia Germany Greece Poland

  • Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Agrostis Stolonifera Pollen
    • Alnus Glutinosa Pollen
    • Aluminium Hydroxide
    Austria Bulgaria Germany Latvia Lithuania Poland

  • Study on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Lebrikizumab
    Germany Poland
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!